» Articles » PMID: 1246330

Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1976 Feb 26
PMID 1246330
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Glucagon was infused to maintain plasma concentrations three to six times the basal level (300 to 600 pg per milliliter) into 16 normal and seven non-diabetic obese subjects. Hyperglucagonemia caused only a transient rise of 5 to 10 mg per 100 ml in basal glucose levels and had no effect on oral glucose tolerance or plasma insulin. In three patients with adult and two with juvenile-onset diabetes on maintenance insulin, hyperglucagonemia maintained for two to four days caused no change in plasma glucose of ketone concentration. In contrast, in nine insulin-withdrawn patients the glycemic response to hyperglucagonemia was five to 15 times greater (P less then 0.05) than in normal controls. Hyperglucagonemia does not cause glucose intolerance in normal subjects or bring about deterioration of diabetic control when insulin is available. Glucagon in the insulin-deprived patient can worsen the diabetic state. These findings suggest the primary role of insulin deficiency in the diabetogenic action of glucagon.

Citing Articles

Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus.

Chang L, Ma X, Yuan M, Ding L, Gu Y, Liu L Diabetes Metab Syndr Obes. 2024; 17:1769-1780.

PMID: 38645659 PMC: 11032662. DOI: 10.2147/DMSO.S459392.


The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesity.

Grondahl M, Bagger J, Suppli M, van Hall G, Albrechtsen N, Holst J Endocr Connect. 2024; 13(3).

PMID: 38276866 PMC: 10959036. DOI: 10.1530/EC-23-0516.


High Doses of Exogenous Glucagon Stimulate Insulin Secretion and Reduce Insulin Clearance in Healthy Humans.

Gray S, Goonatilleke E, Emrick M, Becker J, Hoofnagle A, Stefanovski D Diabetes. 2023; 73(3):412-425.

PMID: 38015721 PMC: 10882148. DOI: 10.2337/db23-0201.


Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action.

Lubaczeuski C, Bozadjieva-Kramer N, Louzada R, Gittes G, Leibowitz G, Bernal-Mizrachi E JCI Insight. 2023; 8(11).

PMID: 37140984 PMC: 10393226. DOI: 10.1172/jci.insight.162255.


It takes guts to learn: machine learning techniques for disease detection from the gut microbiome.

Curry K, Nute M, Treangen T Emerg Top Life Sci. 2021; 5(6):815-827.

PMID: 34779841 PMC: 8786294. DOI: 10.1042/ETLS20210213.